Robert Kramer - 28 Feb 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
President and CEO, Director
Signature
/s/ Jennifer Lynn Fox, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
28 Feb 2023
Net transactions value
-$39,938
Form type
4
Filing time
02 Mar 2023, 13:42:04 UTC
Previous filing
27 Feb 2023
Next filing
06 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability $39,938 -3,226 -3% $12.38 103,298 28 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.